ENVB
Enveric Biosciences, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:B-
Company Profile
CEO
Joseph Edward Tucker
IPO Date
2015-05-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Enveric Biosciences, Inc.
CEO
Joseph Edward Tucker
IPO Date
2015-05-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 7,633 |
| $0.00 |
| 30 Dec 2025 | PASQUALONE FRANK | director | A-Award | Acquired | 7,633 | $0.00 |
| 30 Dec 2025 | Schabacker Marcus | director | A-Award | Acquired | 7,633 | $0.00 |
| 30 Dec 2025 | Tucker Joseph Edward | director, officer: Chief Executive Officer | A-Award | Acquired | 60,296 | $0.00 |
| 30 Dec 2025 | WEBB MICHAEL D | director | A-Award | Acquired | 7,633 | $0.00 |
| 30 Dec 2025 | Coveney Kevin Michael | Chief Financial Officer | A-Award | Acquired | 40,198 | $0.00 |
| 11 Oct 2024 | Schabacker Marcus | director | A-Award | Acquired | 47,733 | $0.00 |
| 11 Oct 2024 | PASQUALONE FRANK | director | A-Award | Acquired | 47,733 | $0.00 |
| 11 Oct 2024 | Kegler George A. | director | A-Award | Acquired | 47,733 | $0.00 |